{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:33:42Z","timestamp":1790886822294,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2006,10,24]],"date-time":"2006-10-24T00:00:00Z","timestamp":1161648000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1038\/sj.bjc.6603444","type":"journal-article","created":{"date-parts":[[2006,10,24]],"date-time":"2006-10-24T18:48:55Z","timestamp":1161715735000},"page":"1410-1414","source":"Crossref","is-referenced-by-count":56,"title":["Activated c-SRC in ductal carcinoma in situ correlates with high tumour grade, high proliferation and HER2 positivity"],"prefix":"10.1038","volume":"95","author":[{"given":"G R","family":"Wilson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Cramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Welman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Knox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Swindell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Kawakatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R B","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Dive","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N J","family":"Bundred","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,10,24]]},"reference":[{"key":"BF6603444_CR1","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1158\/1078-0432.CCR-04-1633","volume":"11","author":"NL Barnes","year":"2005","unstructured":"Barnes NL, Khavari S, Boland GP, Cramer A, Knox WF, Bundred NJ (2005) Absence of HER4 expression predicts recurrence of ductal carcinoma in situ of the breast. Clin Cancer Res 11: 2163\u20132168","journal-title":"Clin Cancer Res"},{"key":"BF6603444_CR2","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1038\/sj.onc.1204205","volume":"20","author":"AP Belsches-Jablonski","year":"2001","unstructured":"Belsches-Jablonski AP, Biscardi JS, Peavy DR, Tice DA, Romney DA, Parsons SJ (2001) Src family kinases and HER2 interactions in human breast cancer cell growth and survival. Oncogene 20: 1465\u20131475","journal-title":"Oncogene"},{"key":"BF6603444_CR3","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/sj.bjc.6601534","volume":"90","author":"GP Boland","year":"2004","unstructured":"Boland GP, Butt IS, Prasad R, Knox WF, Bundred NJ (2004) COX-2 expression is associated with an aggressive phenotype in ductal carcinoma in situ. Br J Cancer 90: 423\u2013429","journal-title":"Br J Cancer"},{"key":"BF6603444_CR4","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1158\/1078-0432.CCR-04-1749","volume":"12","author":"N Diaz","year":"2006","unstructured":"Diaz N, Minton S, Cox C, Bowman T, Gritsko T, Garcia R, Eweis I, Wloch M, Livingston S, Seijo E, Cantor A, Lee JH, Beam CA, Sullivan D, Jove R, Muro-Cacho CA (2006) Activation of stat3 in primary tumors from high-risk breast cancer patients is associated with elevated levels of activated SRC and survivin expression. Clin Cancer Res 12: 20\u201328","journal-title":"Clin Cancer Res"},{"key":"BF6603444_CR5","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1002\/(SICI)1097-0142(19990801)86:3<429::AID-CNCR11>3.0.CO;2-Y","volume":"86","author":"ER Fisher","year":"1999","unstructured":"Fisher ER, Dignam J, Tan-Chiu E, Costantino J, Fisher B, Paik S, Wolmark N (1999) Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: intraductal carcinoma. Cancer 86: 429\u2013438","journal-title":"Cancer"},{"key":"BF6603444_CR6","first-page":"114","volume":"1602","author":"MC Frame","year":"2002","unstructured":"Frame MC (2002) Src in cancer: deregulation and consequences for cell behaviour. Biochim Biophys Acta 1602: 114\u2013130","journal-title":"Biochim Biophys Acta"},{"key":"BF6603444_CR7","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1242\/jcs.01111","volume":"117","author":"MC Frame","year":"2004","unstructured":"Frame MC (2004) Newest findings on the oldest oncogene; how activated src does it. J Cell Sci 117: 989\u2013998","journal-title":"J Cell Sci"},{"key":"BF6603444_CR8","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1101\/gad.8.1.23","volume":"8","author":"CT Guy","year":"1994","unstructured":"Guy CT, Muthuswamy SK, Cardiff RD, Soriano P, Muller WJ (1994) Activation of the c-Src tyrosine kinase is required for the induction of mammary tumors in transgenic mice. Genes Dev 8: 23\u201332","journal-title":"Genes Dev"},{"key":"BF6603444_CR9","doi-asserted-by":"publisher","first-page":"5636","DOI":"10.1038\/sj.onc.1203912","volume":"19","author":"RB Irby","year":"2000","unstructured":"Irby RB, Yeatman TJ (2000) Role of Src expression and activation in human cancer. Oncogene 19: 5636\u20135642","journal-title":"Oncogene"},{"key":"BF6603444_CR10","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1023\/A:1020860221099","volume":"76","author":"Y Ito","year":"2002","unstructured":"Ito Y, Kawakatsu H, Takeda T, Tani N, Kawaguchi N, Noguchi S, Sakai T, Matsuura N (2002) Activation of c-Src is inversely correlated with biological aggressiveness of breast carcinoma. Breast Cancer Res Treat 76: 261\u2013267","journal-title":"Breast Cancer Res Treat"},{"key":"BF6603444_CR11","first-page":"1696","volume":"43","author":"C Jacobs","year":"1983","unstructured":"Jacobs C, Rubsamen H (1983) Expression of pp60c-src protein kinase in adult and fetal human tissue: high activities in some sarcomas and mammary carcinomas. Cancer Res 43: 1696\u20131702","journal-title":"Cancer Res"},{"key":"BF6603444_CR12","doi-asserted-by":"publisher","first-page":"5680","DOI":"10.1074\/jbc.271.10.5680","volume":"271","author":"H Kawakatsu","year":"1996","unstructured":"Kawakatsu H, Sakai T, Takagaki Y, Shinoda Y, Saito M, Owada MK, Yano J (1996) A new monoclonal antibody which selectively recognizes the active form of Src tyrosine kinase. J Biol Chem 271: 5680\u20135685","journal-title":"J Biol Chem"},{"key":"BF6603444_CR13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.humpath.2005.09.024","volume":"37","author":"R Madan","year":"2006","unstructured":"Madan R, Smolkin MB, Cocker R, Fayyad R, Oktay MH (2006) Focal adhesion proteins as markers of malignant transformation and prognostic indicators in breast carcinoma. Hum Pathol 37: 9\u201315","journal-title":"Hum Pathol"},{"key":"BF6603444_CR14","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0065-230X(08)60836-2","volume":"64","author":"SK Muthuswamy","year":"1994","unstructured":"Muthuswamy SK, Muller WJ (1994) Activation of the Src family of tyrosine kinases in mammary tumorigenesis. Adv Cancer Res 64: 111\u2013123","journal-title":"Adv Cancer Res"},{"key":"BF6603444_CR15","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1128\/MCB.14.1.735","volume":"14","author":"SK Muthuswamy","year":"1994","unstructured":"Muthuswamy SK, Siegel PM, Dankort DL, Webster MA, Muller WJ (1994) Mammary tumors expressing the neu proto-oncogene possess elevated c-Src tyrosine kinase activity. Mol Cell Biol 14: 735\u2013743","journal-title":"Mol Cell Biol"},{"key":"BF6603444_CR16","first-page":"5028","volume":"63","author":"A Myoui","year":"2003","unstructured":"Myoui A, Nishimura R, Williams PJ, Hiraga T, Tamura D, Michigami T, Mundy GR, Yoneda T (2003) C-SRC tyrosine kinase activity is associated with tumor colonization in bone and lung in an animal model of human breast cancer metastasis. Cancer Res 63: 5028\u20135033","journal-title":"Cancer Res"},{"key":"BF6603444_CR17","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1023\/A:1006596620406","volume":"17","author":"H Noritake","year":"1999","unstructured":"Noritake H, Miyamori H, Goto C, Seiki M, Sato H (1999) Overexpression of tissue inhibitor of matrix metalloproteinases-1 (TIMP-1) in metastatic MDCK cells transformed by v-src. Clin Exp Metastasis 17: 105\u2013110","journal-title":"Clin Exp Metastasis"},{"key":"BF6603444_CR18","first-page":"4773","volume":"52","author":"AE Ottenhoff-Kalff","year":"1992","unstructured":"Ottenhoff-Kalff AE, Rijksen G, van Beurden EA, Hennipman A, Michels AA, Staal GE (1992) Characterization of protein tyrosine kinases from human breast cancer: involvement of the c-src oncogene product. Cancer Res 52: 4773\u20134778","journal-title":"Cancer Res"},{"key":"BF6603444_CR19","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.bbrc.2005.12.164","volume":"341","author":"MD Planas-Silva","year":"2006","unstructured":"Planas-Silva MD, Bruggeman RD, Grenko RT, Stanley Smith J (2006) Role of c-Src and focal adhesion kinase in progression and metastasis of estrogen receptor-positive breast cancer. Biochem Biophys Res Commun 341: 73\u201381","journal-title":"Biochem Biophys Res Commun"},{"key":"BF6603444_CR20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1006\/bbrc.1998.9214","volume":"250","author":"LG Sheffield","year":"1998","unstructured":"Sheffield LG (1998) C-Src activation by ErbB2 leads to attachment-independent growth of human breast epithelial cells. Biochem Biophys Res Commun 250: 27\u201331","journal-title":"Biochem Biophys Res Commun"},{"key":"BF6603444_CR21","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1126\/science.3798106","volume":"235","author":"DJ Slamon","year":"1987","unstructured":"Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2\/neu oncogene. Science 235: 177\u2013182","journal-title":"Science"},{"key":"BF6603444_CR22","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1158\/0008-5472.CAN-04-2353","volume":"65","author":"M Tan","year":"2005","unstructured":"Tan M, Li P, Klos KS, Lu J, Lan KH, Nagata Y, Fang D, Jing T, Yu D (2005) ErbB2 promotes Src synthesis and stability: novel mechanisms of Src activation that confer breast cancer metastasis. Cancer Res 65: 1858\u20131867","journal-title":"Cancer Res"},{"key":"BF6603444_CR23","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/(SICI)1096-9896(199612)180:4<383::AID-PATH686>3.0.CO;2-N","volume":"180","author":"BS Verbeek","year":"1996","unstructured":"Verbeek BS, Vroom TM, Adriaansen-Slot SS, Ottenhoff-Kalff AE, Geertzema JG, Hennipman A, Rijksen G (1996) c-Src protein expression is increased in human breast cancer. An immunohistochemical and biochemical analysis. J Pathol 180: 383\u2013388","journal-title":"J Pathol"},{"key":"BF6603444_CR24","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1200\/JCO.2002.20.3.719","volume":"20","author":"CL Vogel","year":"2002","unstructured":"Vogel CL, Cobleigh MA, Tripathy D, Gutheil JC, Harris LN, Fehrenbacher L, Slamon DJ, Murphy M, Novotny WF, Burchmore M, Shak S, Stewart SJ, Press M (2002) Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer. J Clin Oncol 20: 719\u2013726","journal-title":"J Clin Oncol"},{"key":"BF6603444_CR25","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1002\/jcb.20342","volume":"94","author":"A Welman","year":"2005","unstructured":"Welman A, Cawthorne C, Barraclough J, Smith N, Griffiths GJ, Cowen RL, Williams JC, Stratford IJ, Dive C (2005) Construction and characterization of multiple human colon cancer cell lines for inducibly regulated gene expression. J Cell Biochem 94: 1148\u20131162","journal-title":"J Cell Biochem"},{"key":"BF6603444_CR26","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/nrc1366","volume":"4","author":"TJ Yeatman","year":"2004","unstructured":"Yeatman TJ (2004) A renaissance for SRC. Nat Rev Cancer 4: 470\u2013480","journal-title":"Nat Rev Cancer"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6603444.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6603444","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6603444.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:24:23Z","timestamp":1684412663000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6603444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10,24]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["BF6603444"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6603444","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,10,24]]}}}